Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group.

Source:http://linkedlifedata.com/resource/pubmed/id/10561210

Download in:

View as

General Info

PMID
10561210